Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(17%)
Results Posted
25%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
5
83%
Ph phase_3
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (16.7%)
N/A5 (83.3%)

Trials by Status

recruiting117%
completed467%
terminated117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
6